FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - ANAL CANAL





Form # 785-1-025

CLIN  PATH  DEFINITIONS
    PRIMARY TUMOR (T)
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumor 2 cm or less in greatest dimension
T2 Tumor more than 2 cm but not more than 5 cm in greatest dimension
T3 Tumor more than 5 cm in greatest dimension
T4 Tumor of any size invades adjacent organ(s): e.g., vagina, urethra, bladder (involvement of sphincter muscle(s) alone is not classified as T4)
    LYMPH NODE (N)
NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in perirectal lymph node(s)
N2 Metastasis in unilateral internal iliac and/or inguinal lymph node(s)
N3 Metastasis in perirectal and inguinal lymph nodes and/or bilateral internal iliac and/or inguinal lymph nodes
    DISTANT METASTASIS (M)
MX Presence of distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metastasis

Pathologic Stage by: M.D. Date:

CLIN PATH STAGE GROUPING

0 Tis N0 M0

I T1 N0 M0

II T2 N0 M0
      T3 N0 M0

IIIA T1 N1 M0
      T2 N1 M0
      T3 N1 M0
      T4 N0 M0
      T4 N1 M0
      Any T N2 M0
      Any T N3 M0

IV Any T Any N M1

 Attending: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:
Patient Name: